CLOUDBREAK THERAPEUTICS
Cloudbreak Therapeutics is a clinical-stage biotechnology company focusing on ocular drug development. Cloudbreak Therapeutics operates a capital efficient business model based upon VIC + 505b(2). We repurpose approved systemic drugs for ocular delivery to treat eye diseases and quickly advance drug candidates to complete proof-of-concept (POC) Phase II clinical trials and to out-license global rights for Phase III clinical trials, product registration, and commercialization. Fully embracing the pharmaceutical development ecosystem, we utilize contract research organizations (CRO) for non-clinical, CMC and clinical development to efficiently maximize capital for drug development.
CLOUDBREAK THERAPEUTICS
Industry:
Biotechnology Health Care
Founded:
2015-09-01
Address:
Irvine, California, United States
Country:
United States
Website Url:
http://www.cloudbreaktherapeutics.com
Total Employee:
11+
Status:
Active
Total Funding:
171.22 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag
Similar Organizations
Lion TCR
Lion TCR is a clinical-stage biotechnology company.
Rain Therapeutics
Rain Therapeutics is a operator of a clinical stage biotechnology company.
Current Employees Featured
Founder
Investors List
EFung Capital
EFung Capital investment in Series C - Cloudbreak Therapeutics
Industrial Securities Capital
Industrial Securities Capital investment in Series C - Cloudbreak Therapeutics
Grand Pharmaceutical
Grand Pharmaceutical investment in Series C - Cloudbreak Therapeutics
CDF-Capital
CDF-Capital investment in Series C - Cloudbreak Therapeutics
CDH Investments
CDH Investments investment in Series C - Cloudbreak Therapeutics
Yuejun Investment
Yuejun Investment investment in Series C - Cloudbreak Therapeutics
Dyee Capital
Dyee Capital investment in Series C - Cloudbreak Therapeutics
Yingke Capital
Yingke Capital investment in Series C - Cloudbreak Therapeutics
ShenZhen GTJA Investment Group
ShenZhen GTJA Investment Group investment in Series C - Cloudbreak Therapeutics
CCB International
CCB International investment in Series C - Cloudbreak Therapeutics
Official Site Inspections
http://www.cloudbreaktherapeutics.com
- Host name: 217.70.196.104.bc.googleusercontent.com
- IP address: 104.196.70.217
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
